Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s What Happened

Shares of Hypermarcas (OTCMKTS:HYPMY) gapped down prior to trading on Friday . The stock had previously closed at $4.27, but opened at $4.14. Hypermarcas shares last traded at $4.12, with a volume of 1,585 shares traded.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Hypermarcas Stock Performance

The firm has a fifty day simple moving average of $4.10 and a 200 day simple moving average of $4.29. The company has a market cap of $2.90 billion, a PE ratio of 8.24 and a beta of 0.70.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. As a group, equities analysts predict that Hypermarcas will post 0.53 EPS for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.